Clinical study boosts Proteomics kidney test – The West Australian

Medical technology innovator Proteomics says a US clinical utility study on its PromarkerD predictive test for diabetic kidney disease has shown the test to be more important to a physician who is monitoring a patients condition than the existing standard…

Click here to view the original article.